The Antisense Architect: Dr. Stanley T. Crooke’s Legacy in Biotechnology
Dr. Stanley T. Crooke’s (Executive Chairman, Ionis Pharmaceuticals Inc.) story is one of a visionary who transformed the landscape of biotechnology. His
Dr. Stanley T. Crooke’s (Executive Chairman, Ionis Pharmaceuticals Inc.) story is one of a visionary who transformed the landscape of biotechnology. His
Traditional drug discovery is slow, costly, and often fails. Insilico Medicine’s Chief Business Officer, trained in biology and mentored by
The air in the community hall in Kalamazoo is thick with the kind of silence that precedes a difficult truth.
The idea of a lawyer who moonlights as an aspiring stand-up comic seems, at first, like the setup to a
The screen flickers to life not with a bang, but with a palpable sense of calm. On the other end
The Bay Area, with its vibrant, sun-drenched landscape and a reputation for relentless innovation, has long been a place where
The journey from a promising biopharmaceutical concept in a research lab to a life-changing medicine reaching patients is fraught with
There’s a quiet revolution brewing in the pharmaceutical world. It doesn’t involve a blockbuster new drug or a gleaming, billion-dollar
Charles A. Blumstein recognized a fracture in healthcare. The COVID-19 pandemic laid bare its vulnerabilities. Hospitals, long the default centers
Jennifer Pinasco carries a distinct definition of success. Most leaders measure it in financial growth alone. Pinasco, however, begins with
Michael Rasche grasps the enormous weight of his task. As Chief Executive Officer of Diadem SpA, he leads a company
Howard Rosen stands in a peculiar position. He leads Nova Insights, a firm dedicated to digital transformation in healthcare, yet